Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Danicopan Regulatory Post-Marketing Study in Korea

NCT07457151 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT07457151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07457151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Danicopan Regulatory Post-Marketing Study in Korea
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Recruiting
Start date
April 10, 2026
Completion date
June 27, 2028
Enrollment
27 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal nocturnal hemoglobinuria